DexCom, Inc. (DXCM)
DexCom Market Cap : 34.36B for Aug. 24, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 34.85B |
| August 20, 2026 | 34.05B |
| August 19, 2026 | 33.92B |
| August 18, 2026 | 33.82B |
| August 17, 2026 | 33.50B |
| August 14, 2026 | 33.87B |
| August 13, 2026 | 34.52B |
| August 12, 2026 | 34.27B |
| August 11, 2026 | 33.79B |
| August 10, 2026 | 33.08B |
| August 07, 2026 | 31.98B |
| August 06, 2026 | 31.33B |
| August 05, 2026 | 31.20B |
| August 04, 2026 | 32.81B |
| August 03, 2026 | 32.95B |
| July 31, 2026 | 31.49B |
| July 30, 2026 | 28.13B |
| July 29, 2026 | 28.36B |
| July 28, 2026 | 28.25B |
| July 27, 2026 | 27.69B |
| July 24, 2026 | 27.61B |
| July 23, 2026 | 27.20B |
| July 22, 2026 | 27.56B |
| July 21, 2026 | 28.85B |
| July 20, 2026 | 29.21B |
| Date | Value |
|---|---|
| July 17, 2026 | 29.58B |
| July 16, 2026 | 30.09B |
| July 15, 2026 | 28.07B |
| July 14, 2026 | 28.60B |
| July 13, 2026 | 29.46B |
| July 10, 2026 | 28.93B |
| July 09, 2026 | 28.18B |
| July 08, 2026 | 28.58B |
| July 07, 2026 | 28.39B |
| July 06, 2026 | 27.93B |
| July 02, 2026 | 27.50B |
| July 01, 2026 | 26.57B |
| June 30, 2026 | 25.99B |
| June 29, 2026 | 27.01B |
| June 26, 2026 | 27.07B |
| June 25, 2026 | 26.49B |
| June 24, 2026 | 26.92B |
| June 23, 2026 | 26.60B |
| June 22, 2026 | 26.65B |
| June 18, 2026 | 27.97B |
| June 17, 2026 | 27.49B |
| June 16, 2026 | 28.23B |
| June 15, 2026 | 28.64B |
| June 12, 2026 | 29.09B |
| June 11, 2026 | 29.04B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Abbott Laboratories | 201.88B |
| Insulet Corp. | 10.10B |
| Baxter International, Inc. | 13.70B |
| Globus Medical, Inc. | 11.29B |
| Stryker Corp. | 125.75B |
Market Cap Related Metrics
| PE Ratio | 35.94 |
| PS Ratio | 7.283 |
| PEG Ratio | 0.4646 |
| Price to Book Value | 13.11 |
| Price to Free Cash Flow | 25.76 |
| Price | 91.04 |
| Earnings Yield | 2.78% |
| PEGY Ratio | 0.4646 |
| Operating PE Ratio | 31.77 |
| Normalized PE Ratio | 35.94 |